We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
26
Procter & Gamble
PG
$343B
$842K 0.51%
5,108
+1,600
+46% +$262K
CNTA
27
DELISTED
Centessa Pharmaceuticals
CNTA
$840K 0.51%
+93,000
New +$882K
IWN icon
28
iShares Russell 2000 Value ETF
IWN
$14.4B
$832K 0.5%
5,466
+303
+6% +$46.3K
VOO icon
29
Vanguard S&P 500 ETF
VOO
$968B
$778K 0.47%
1,555
– –
PLRX icon
30
Pliant Therapeutics
PLRX
$67.5M
$726K 0.44%
67,500
+25,000
+59% +$322K
FNA
31
DELISTED
Paragon 28, Inc.
FNA
$661K 0.4%
96,611
– –
IJJ icon
32
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
$639K 0.38%
5,628
-190
-3% -$21.7K
VTI icon
33
Vanguard Total Stock Market ETF
VTI
$654B
$627K 0.38%
2,344
– –
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$625K 0.38%
1,149
-85
-7% -$44.5K
XEL icon
35
Xcel Energy
XEL
$51B
$614K 0.37%
11,501
+131
+1% +$7.13K
AMZN icon
36
Amazon
AMZN
$2.5T
$606K 0.36%
3,134
-63
-2% -$11.6K
SHY icon
37
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$593K 0.36%
7,268
-486
-6% -$39.5K
IJS icon
38
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$584K 0.35%
6,005
-206
-3% -$20.2K
AUPH icon
39
Aurinia Pharmaceuticals
AUPH
$1.97B
$521K 0.31%
91,196
+16,000
+21% +$84.3K
ECL icon
40
Ecolab
ECL
$75.6B
$492K 0.3%
2,066
+37
+2% +$8.55K
ABT icon
41
Abbott
ABT
$180B
$437K 0.26%
4,210
– –
VV icon
42
Vanguard Large-Cap ETF
VV
$51.9B
$416K 0.25%
1,668
– –
OEF icon
43
iShares S&P 100 ETF
OEF
$19.8B
$406K 0.24%
1,538
-81
-5% -$20.3K
HSBC icon
44
HSBC
HSBC
$355B
$395K 0.24%
9,077
+2
+0% +$86
XOM icon
45
ExxonMobil
XOM
$651B
$356K 0.21%
3,095
+76
+3% +$8.85K
DXCM icon
46
DexCom
DXCM
$27.6B
$344K 0.21%
3,036
+16
+0.5% +$2.02K
PRTA icon
47
Prothena Corp
PRTA
$458M
$341K 0.21%
16,502
– –
COST icon
48
Costco
COST
$415B
$326K 0.2%
384
– –
KRMD icon
49
KORU Medical Systems
KRMD
$176M
$320K 0.19%
120,935
– –
PRLB icon
50
Protolabs
PRLB
$1.86B
$307K 0.18%
9,945
– –
1
2
3 4 5

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.